Skip to main content

Table 2 HBV serological markers characteristics of participants, number (%)

From: Effects of Let-7c on the processing of hepatitis B virus associated liver diseases

  

HBsAg

anti-HBs

HBeAg

anti-HBe

DEPa

HBV DNA

Total

 + 

100 (92.59)

3 (2.78)

74 (68.52)

45 (41.67)

13 (12.04)

89 (82.41)

 − 

8 (7.41)

105 (97.22)

34 (31.48)

63 (58.33)

95 (87.96)

19 (17.59)

B-CH

 + 

82 (91.11)

3 (3.33)

68 (75.56)

31 (34.44)

11 (12.22)

79 (87.78)

 − 

8 (8.89)

87 (96.67)

22 (24.44)

59 (65.56)

79 (87.78)

11 (12.22)

B-LC

 + 

10 (100.00)

0

5 (50.00)

7 (70.00)c

2 (20.00)

9 (90.00)

 − 

0

10 (100.00)

5 (50.00)

3 (30.00)

8 (80.00)

1 (10.00)

B-HCC

 + 

8 (100.00)

0

1 (12.50)d

7 (87.50)d

0

1 (12.50)d,e

 − 

0

8 (100.00)

7 (87.50)

1 (12.50)

8 (100.00)

7 (87.50)

P valueb

 

N.S

N.S

 < 0.05

 < 0.05

N.S

 < 0.05

  1. aDEP: dual-positivity for both HBeAg and anti-HBe
  2. bCompared 3 groups (B-CH, B-LC and B-HCC), calculated by Chi-square test
  3. cP < 0.05, compared between B-CH and B-LC, calculated by Chi-square test
  4. dP < 0.05, compared between B-CH and B-HCC, calculated by Chi-square test
  5. eP < 0.05, compared between B-LC and B-HCC, calculated by Chi-square test